MYD88 and metabolic dysfunction-associated steatohepatitis: HMGB1 and IL-33 are released from dying hepatocytes and showed significant upregulation in mice during NASH progression (13), in which HMGB1 activates TLR4 and the adaptor protein myeloid differentiation primary response 88 (MyD88) (14).